China Shineway Pharmaceutical at 22-month peak on strong Q1 turnover

China Shineway Pharmaceutical

08/05/2023 06:38

** Shares of modern Chinese medicines developer and
manufacturer China Shineway Pharmaceutical Group Ltd  2877.HK 
jump as much as 8.3% to HK$9.52, their highest since July 2021
    ** Hebei-based co says its turnover for Q1 2023 jumped 35.6%
YOY to 1.19 bln yuan ($172.11 mln), of which injection products
soared 38.9% YOY, soft capsule products surged 21.7% YOY and
Traditional Chinese Medicine (TCM) formula granule products up
47.7% 
    ** The Hang Seng Commerce & Industry Index  .HSNC  gains
0.2%, while healthcare index  .HSCIH  slips 1%
    ** The Hang Seng Composite Index  .HSCI  climbs 0.5% and the
Hang Seng Index  .HSI  adds 0.7%
    ** As of last close, the stock had risen 15.8% this year
($1 = 6.9142 Chinese yuan renminbi)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))